Maquet buys LAA closure device developer

Candace Stuart | | Cardiovascular Business | Heart Rhythm

Maquet Cardiovascular has acquired LAAx, the developer of an implantable left atrial appendage (LAA) closure device.

LAAx makes the TigerPaw System II, a mechanical occlusion device that is indicated for the occlusion of the LAA under direct visualization, in conjunction with other open cardiac surgical procedures. The device is approved in the U.S. and the European Union, according Rastatt, Germany-based Maquet.

The implanted TigerPaw System II uses a single-use delivery tool and an implantable fastener to occlude the LAA during open chest procedures. “We believe TigerPaw II will be a best-in-class device for reliable ligation of the LAA, potentially mitigating post-operative stroke and its associated costs in patients with atrial fibrillation undergoing cardiac surgery,” Peter Hinchliffe, president and CEO for the Cardiac Surgery Business Unit of Maquet, said in a release.

LAAx is based in Livermore, Calif. Terms of the acquisition were not disclosed.

Candace Stuart, Contributor

Related Content

FDA announces recall of cryoablation catheters after multiple injuries, including 4 deaths
Cardiologists perform world’s first leadless LBBAP procedures with Abbott pacemaker
President of medical device company resigns over conduct allegations after 7 months in role
FDA and Boston Scientific issue urgent alert about pacemaker failures following 2 deaths
Treating AFib patients with TAVR still linked to elevated risks
Cardiologists work to standardize the diagnosis and management of acute myocarditis

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.